Abstract
Patients suffering from pathological pain due to neuropathy or chronic inflammation are dependent on treatment with efficient and highly specific drugs. Although a number of analgesics are available many patients cannot be adequately treated because of lacking efficacy or severe side effects. The pain hypersensitivity in inflammatory and neuropathic pain is associated with changes of protein expression in the CNS which are not completely clarified at the moment. To develop novel treatment strategies it is necessary to elucidate the mechanisms of both pain states, and to find proteins that are specifically regulated in either neuropathic or inflammatory pain and that may become drug targets.
Proteomics by 2D-gel electrophoresis combined with MALDI-TOF mass spectrometry might help identifying regulated proteins in the nervous system in inflammatory or neuropathic pain models and therefore facilitate the development of novel analgesics. In these chapter a number of proteomic approaches in the field of inflammatory pain and nerve injury are reviewed which might provide starting points for further research in this field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CCI:
-
chronic constriction injury
- IEF:
-
isoelectric focusing
- IPG:
-
immobilized pH gradient
- MALDI-TOF MS:
-
matrix-assisted laser desorption ionization time-of-flight mass spectrometry
- MW:
-
molecular weight
- NC:
-
nerve crush
- SNI:
-
spared nerve injury
- SNL:
-
spinal nerve ligation
References
Alzate, O., Hussain, S. R., Goettl, V. M., Tewari, A. K., Madiai, F., Stephens, R. L., Jr., et al. (2004). Proteomic identification of brainstem cytosolic proteins in a neuropathic pain model. Brain Research. Molecular Brain Research, 128, 193–200.
Anderson, T. E. (1982). A controlled pneumatic technique for experimental spinal cord contusion. Journal of Neuroscience Methods, 6, 327–333.
Arimura, N., Menager, C., Fukata, Y., & Kaibuchi, K. (2004). Role of CRMP-2 in neuronal polarity. Journal of Neurobiology, 58, 34–47.
Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G., & Goppelt-Struebe, M. (1996). Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Letters, 390, 165–169.
Bennett, A. D., Chastain, K. M., & Hulsebosch, C. E. (2000). Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain. Pain, 86, 163–175.
Bennett, G. J., & Xie, Y. K. (1988). A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33, 87–107.
Boyles, J. K., Notterpek, L. M., & Anderson, L. J. (1990). Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. The Journal of Biological Chemistry, 265, 17805–17815.
Burre, J., Beckhaus, T., Corvey, C., Karas, M., Zimmermann, H., & Volknandt, W. (2006). Synaptic vesicle proteins under conditions of rest and activation: analysis by 2-D difference gel electrophoresis. Electrophoresis, 27, 3488–3496.
Campbell, J. N., & Meyer, R. A. (2006). Mechanisms of neuropathic pain. Neuron, 52, 77–92.
Chen, H., Lamer, T. J., Rho, R. H., Marshall, K. A., Sitzman, B. T., Ghazi, S. M., et al. (2004). Contemporary management of neuropathic pain for the primary care physician. Mayo Clinic Proceedings, 79, 1533–1545.
Choi, Y., Yoon, Y. W., Na, H. S., Kim, S. H., & Chung, J. M. (1994). Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain, 59, 369–376.
Choudhary, J., & Grant, S. G. (2004). Proteomics in postgenomic neuroscience: the end of the beginning. Nature Neuroscience, 7, 440–445.
Christensen, M. D., Everhart, A. W., Pickelman, J. T., & Hulsebosch, C. E. (1996). Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain, 68, 97–107.
Christensen, M. D., & Hulsebosch, C. E. (1997). Chronic central pain after spinal cord injury. Journal of Neurotrauma, 14, 517–537.
Costigan, M., Mannion, R. J., Kendall, G., Lewis, S. E., Campagna, J. A., Coggeshall, R. E., et al. (1998). Heat shock protein 27: developmental regulation and expression after peripheral nerve injury. The Journal of Neuroscience, 18, 5891–5900.
Dubner, R. (1994). Methods of assessing pain in animals. In P. D. Wall & R. Melzack (Eds.), Textbook of pain (pp. 293–302). Edinburgh: Churchill Livingston.
Dubner, R., & Ren, K. E. (1999). Assessing transient and persistent pain in animals. In P. D. Wall & R. Melzack (Eds.), Textbook of pain (pp. 359–369). Edinburgh: Churchill Livingston.
Dubner, R., & Ruda, M. A. (1992). Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends in Neurosciences, 15, 96–103.
Fabrizi, G. M., Cavallaro, T., Angiari, C., Cabrini, I., Taioli, F., Malerba, G., et al. (2006). Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain, 130(Pt 2), 394–403.
Feasson, L., Stockholm, D., Freyssenet, D., Richard, I., Duguez, S., Beckmann, J. S., et al. (2002). Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle. Journal de Physiologie, 543, 297–306.
George, A., Marziniak, M., Schafers, M., Toyka, K. V., & Sommer, C. (2000). Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain, 88, 267–275.
Gordh, T., Chu, H., & Sharma, H. S. (2006). Spinal nerve lesion alters blood-spinal cord barrier function and activates astrocytes in the rat. Pain, 124, 211–221.
Gorg, A., Obermaier, C., Boguth, G., Harder, A., Scheibe, B., Wildgruber, R., et al. (2000). The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis, 21, 1037–1053.
Gorg, A., Weiss, W., & Dunn, M. J. (2004). Current two-dimensional electrophoresis technology for proteomics. Proteomics, 4, 3665–3685.
Granville, D. J., & Gottlieb, R. A. (2003). The mitochondrial voltage-dependent anion channel (VDAC) as a therapeutic target for initiating cell death. Current Medicinal Chemistry, 10, 1527–1533.
Greenberg, J., McKeever, P. E., & Balentine, J. D. (1978). Lysosomal activity in experimental spinal cord trauma: an ultrastructural cytochemical evaluation. Surgical Neurology, 9, 361–364.
Gruber, C. W., Cemazar, M., Heras, B., Martin, J. L., & Craik, D. J. (2006). Protein disulfide isomerase: the structure of oxidative folding. Trends in Biochemical Sciences, 31, 455–464.
Hansson, P. T., & Dickenson, A. H. (2005). Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain, 113, 251–254.
Ignatius, M. J., Gebicke-Harter, P. J., Skene, J. H., Schilling, J. W., Weisgraber, K. H., Mahley, R. W., et al. (1986). Expression of apolipoprotein E during nerve degeneration and regeneration. Proceedings of the National Academy of Sciences of the United States of America, 83, 1125–1129.
Ji, R. R., & Woolf, C. J. (2001). Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiology of Disease, 8, 1–10.
Ji, R. R., Zhang, X., Wiesenfeld-Hallin, Z., & Hokfelt, T. (1994). Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. The Journal of Neuroscience, 14, 6423–6434.
Ji, R. R., Zhang, X., Zhang, Q., Dagerlind, A., Nilsson, S., Wiesenfeld-Hallin, Z., et al. (1995). Central and peripheral expression of galanin in response to inflammation. Neuroscience, 68, 563–576.
Jimenez, C. R., Stam, F. J., Li, K. W., Gouwenberg, Y., Hornshaw, M. P., De Winter, F., et al. (2005). Proteomics of the injured rat sciatic nerve reveals protein expression dynamics during regeneration. Molecular & Cellular Proteomics, 4, 120–132.
Kang, S. K., So, H. H., Moon, Y. S., & Kim, C. H. (2006). Proteomic analysis of injured spinal cord tissue proteins using 2-DE and MALDI-TOF MS. Proteomics, 6, 2797–2812.
Katano, T., Mabuchi, T., Okuda-Ashitaka, E., Inagaki, N., Kinumi, T., & Ito, S. (2006). Proteomic identification of a novel isoform of collapsin response mediator protein-2 in spinal nerves peripheral to dorsal root ganglia. Proteomics, 6, 6085–6094.
Kim, S. H., & Chung, J. M. (1992). An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain, 50, 355–363.
Kingery, W. S. (1997). A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain, 73, 123–139.
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., et al. (1999). Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Natural Medicines, 5, 347–350.
Koltzenburg, M. (1998). Painful neuropathies. Current Opinion in Neurology, 11, 515–521.
Komori, N., Takemori, N., Kim, H. K., Singh, A., Hwang, S. H., Foreman, R. D., et al. (2007). Proteomics study of neuropathic and nonneuropathic dorsal root ganglia: altered protein regulation following segmental spinal nerve ligation injury. Physiological Genomics, 29, 215–230.
Kretz, A., Schmeer, C., Tausch, S., & Isenmann, S. (2006). Simvastatin promotes heat shock protein 27 expression and Akt activation in the rat retina and protects axotomized retinal ganglion cells in vivo. Neurobiology of Disease, 21, 421–430.
Kunz, S., Niederberger, E., Ehnert, C., Coste, O., Pfenninger, A., Kruip, J., et al. (2004). The calpain inhibitor MDL 28170 prevents inflammation-induced neurofilament light chain breakdown in the spinal cord and reduces thermal hyperalgesia. Pain, 110, 409–418.
Kunz, S., Tegeder, I., Coste, O., Marian, C., Pfenninger, A., Corvey, C., et al. (2005). Comparative proteomic analysis of the rat spinal cord in inflammatory and neuropathic pain models. Neuroscience Letters, 381, 289–293.
Latchman, D. S. (2005). HSP27 and cell survival in neurones. International Journal of Hyperthermia, 21, 393–402.
Le Bars, D., Gozariu, M., & Cadden, S. W. (2001). Animal models of nociception. Pharmacological Reviews, 53, 597–652.
Lee, S. C., Yoon, T. G., Yoo, Y. I., Bang, Y. J., Kim, H. Y., Jeoung, D. I., et al. (2003). Analysis of spinal cord proteome in the rats with mechanical allodynia after the spinal nerve injury. Biotechnological Letters, 25, 2071–2078.
MacRae, T. H. (2000). Structure and function of small heat shock/alpha-crystallin proteins: established concepts and emerging ideas. Cellular and Molecular Life Sciences, 57, 899–913.
Mannion, R. J., Costigan, M., Decosterd, I., Amaya, F., Ma, Q. P., Holstege, J. C., et al. (1999). Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proceedings of the National Academy of Sciences of the United States of America, 96, 9385–9390.
Matsumoto, H., & Komori, N. (1999). Protein identification on two-dimensional gels archived nearly two decades ago by in-gel digestion and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Analytical Biochemistry, 270, 176–179.
McCarson, K. E., & Krause, J. E. (1994). NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. The Journal of Neuroscience, 14, 712–720.
Meller, S. T., & Gebhart, G. F. (1997). Intraplantar zymosan as a reliable, quantifiable model of thermal and mechanical hyperalgesia in the rat. European Journal of Pain, 1, 43–52.
Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., et al. (2001). Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. The FASEB Journal, 15, 1622–1624.
O’Farrell, P. H. (1975). High resolution two-dimensional electrophoresis of proteins. The Journal of Biological Chemistry, 250, 4007–4021.
Ramana, K. V., Bhatnagar, A., & Srivastava, S. K. (2004). Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells. The FASEB Journal, 18, 1209–1218.
Ramana, K. V., Fadl, A. A., Tammali, R., Reddy, A. B., Chopra, A. K., & Srivastava, S. K. (2006). Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages. The Journal of Biological Chemistry, 281, 33019–33029.
Ramana, K. V., Willis, M. S., White, M. D., Horton, J. W., DiMaio, J. M., Srivastava, D., et al. (2006). Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition. Circulation, 114, 1838–1846.
Rashid, M. H., Inoue, M., Toda, K., & Ueda, H. (2004). Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. The Journal of Pharmacology and Experimental Therapeutics, 309, 380–387.
Rivlin, A. S., & Tator, C. H. (1978). Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surgical Neurology, 10, 38–43.
Rosenfeld, J., Capdevielle, J., Guillemot, J. C., & Ferrara, P. (1992). In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Analytical Biochemistry, 203, 173–179.
Scholz, J., & Woolf, C. J. (2002). Can we conquer pain? Nature Neuroscience, 5(Suppl), 1062–1067.
Seltzer, Z., Dubner, R., & Shir, Y. (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain, 43, 205–218.
Sharma, H. S., Gordh, T., Wiklund, L., Mohanty, S., & Sjoquist, P. O. (2006). Spinal cord injury induced heat shock protein expression is reduced by an antioxidant compound H-290/51. An experimental study using light and electron microscopy in the rat. Journal of Neural Transmission, 113, 521–536.
Sindrup, S. H., & Jensen, T. S. (1999). Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain, 83, 389–400.
Sullivan, P. G., Geiger, J. D., Mattson, M. P., & Scheff, S. W. (2000). Dietary supplement creatine protects against traumatic brain injury. Annals of Neurology, 48, 723–729.
Tanaka, S., Uehara, T., & Nomura, Y. (2000). Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. The Journal of Biological Chemistry, 275, 10388–10393.
Tarlov, I. M. (1972). Acute spinal cord compression paralysis. Journal of Neurosurgery, 36, 10–20.
Tegeder, I., Niederberger, E., Schmidt, R., Kunz, S., Guhring, H., Ritzeler, O., et al. (2004). Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. The Journal of Neuroscience, 24, 1637–1645.
Tjølsen, A., & Hole, K. (1997). Animal models of analgesia. In A. H. Dickenson & J. M. Besson (Eds.), Pharmacology of pain (pp. 1–20). Berlin: Springer.
Varma, T., Liu, S. Q., West, M., Thongboonkerd, V., Ruvolo, P. P., May, W. S., et al. (2003). Protein kinase C-dependent phosphorylation and mitochondrial translocation of aldose reductase. FEBS Letters, 534, 175–179.
Wang, L. X., & Wang, Z. J. (2003). Animal and cellular models of chronic pain. Advanced Drug Delivery Reviews, 55, 949–965.
Woolf, C. J., & Costigan, M. (1999). Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proceedings of the National Academy of Sciences of the United States of America, 96, 7723–7730.
Woolf, C. J., & Mannion, R. J. (1999). Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet, 353, 1959–1964.
Xu, C. J., Klunk, W. E., Kanfer, J. N., Xiong, Q., Miller, G., & Pettegrew, J. W. (1996). Phosphocreatine-dependent glutamate uptake by synaptic vesicles. A comparison with atp-dependent glutamate uptake. The Journal of Biological Chemistry, 271, 13435–13440.
Yabe-Nishimura, C. (1998). Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacological Reviews, 50, 21–33.
Yaksh, T. L., Hua, X. Y., Kalcheva, I., Nozaki-Taguchi, N., & Marsala, M. (1999). The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proceedings of the National Academy of Sciences of the United States of America, 96, 7680–7686.
Yenari, M. A., Giffard, R. G., Sapolsky, R. M., & Steinberg, G. K. (1999). The neuroprotective potential of heat shock protein 70 (HSP70). Molecular Medicine Today, 5, 525–531.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Niederberger, E. (2011). Comparative Proteomic Analysis as a Method to Investigate Inflammatory and Neuropathic Pain. In: Clelland, J. (eds) Genomics, Proteomics, and the Nervous System. Advances in Neurobiology, vol 2. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7197-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7197-5_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7196-8
Online ISBN: 978-1-4419-7197-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)